Osprey Medical
  • Be Kind to Kidneys™
  • Technology
  • About Us
    • Management
    • Board of Directors
    • News
  • Investors
    • Financial Information
    • Releases
    • Events & Presentations
    • Stock Information
    • Corporate Governance
    • Contact Us
  • Search

Investors

  • Financial Information
  • Releases
  • Events & Presentations
  • Stock Information
  • Corporate Governance
  • Contact Us

Osprey Medical is
dedicated to making
angiography safer
for chronic kidney
disease patients.

Osprey Medical designs, develops, and manufactures proprietary devices and monitoring systems that reduce the amount of X-ray dye (contrast) used during commonly performed heart imaging procedures.

Our Mission

To improve outcomes in patients suffering from Chronic Kidney Disease (CKD) by reducing contrast induced Acute Kidney Injury (AKI) and lowering hospital costs.

238%

Year over year revenue growth*

296%

Year over year unit growth*

462%

Year over year new hospitals purchasing*

*FY ’15 to FY ’16

In the News

DyeVert Plus

Cutting Down on Dye May Make Heart Procedures Safer for Kidney Patients

June 8, 2017
San Antonio's University Hospital is one of the first hospitals to use a device called DyeVert Plus. Bluetooth technology embedded in the syringe uses wireless transmission to track exactly how much dye is used for each image. Tests of the new device show it can reduce the amount of dye used in heart procedures on kidney patients by as much as 40 percent.
Read more
https://ospreymed.com/wp-content/uploads/2017/06/tpr-dyevert.jpg 600 800 Rob Coleman /wp-content/uploads/2017/04/osprey-logo-224w.png Rob Coleman2017-06-08 12:00:402017-07-05 20:31:19Cutting Down on Dye May Make Heart Procedures Safer for Kidney Patients
DyeVert™ PLUS System

Osprey Medical Receives US FDA Clearance for DyeVert™ Plus

March 9, 2017
Osprey Medical today announced that it has received US FDA 510(k) clearance for its advanced DyeVert™ PLUS Contrast Reduction System. This new platform augments Osprey's current technology with the capability to actively manage dye administration during coronary interventions.
Read more
https://ospreymed.com/wp-content/uploads/2017/04/DyeVert-PLUS-System.jpg 733 813 Rob Coleman /wp-content/uploads/2017/04/osprey-logo-224w.png Rob Coleman2017-03-09 01:40:312017-07-05 20:13:10Osprey Medical Receives US FDA Clearance for DyeVert™ Plus

All Osprey Medical News

Osprey Medical’s product specific labeling indications may vary by geography.

© 2018 Osprey Medical Inc. All rights reserved.
  • Contact
  • Privacy Policy
  • Terms of Use

Analyst Coverage Disclaimer Please note that any opinions, esimates or forecasts regarding Osprey Medical's performance made by analysts mentioned on this website are theirs alone and do not represent opinions, forecasts or predictions of Osprey Medical or its management. Osprey Medical does not by its reference to any analysts imply its endorsement of or concurrence with their information, conclusions, or recommendations. Information provided by analysts is subject to change, and Osprey Medical cannot guarantee its accuracy.

Check if you have read and acknowledged.

Scroll to top